rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2011-1-3
|
pubmed:abstractText |
The presence of renal failure in patients with multiple myeloma (MM) has been considered an ominous prognostic factor associated with a significantly decreased life expectancy. The prognostic factors have seldom been analyzed to predict discontinuation of hemodialysis (HD) therapy in MM patients with renal failure after HD initiation. It is clinically very important to predict whether HD can be discontinued after introducing HD in such patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium,
http://linkedlifedata.com/resource/pubmed/chemical/Creatinine,
http://linkedlifedata.com/resource/pubmed/chemical/Dexamethasone,
http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin,
http://linkedlifedata.com/resource/pubmed/chemical/Melphalan,
http://linkedlifedata.com/resource/pubmed/chemical/Nitrosourea Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Prednisolone,
http://linkedlifedata.com/resource/pubmed/chemical/Vincristine,
http://linkedlifedata.com/resource/pubmed/chemical/beta 2-Microglobulin,
http://linkedlifedata.com/resource/pubmed/chemical/ranimustine
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1660-2110
|
pubmed:author |
pubmed-author:HagiwaraShotaroS,
pubmed-author:HinoshitaFumihikoF,
pubmed-author:HoshinoTaroT,
pubmed-author:InoueTsuyoshiT,
pubmed-author:KatagiriDaisukeD,
pubmed-author:KatsumaAiA,
pubmed-author:MasumotoShoichiS,
pubmed-author:MinamiEriE,
pubmed-author:NakamuraTaichiT,
pubmed-author:ShibataMakiM,
pubmed-author:ShimboTakuroT,
pubmed-author:TadaManamiM
|
pubmed:copyrightInfo |
Copyright © 2010 S. Karger AG, Basel.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
117
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
c28-32
|
pubmed:meshHeading |
pubmed-meshheading:20689322-Acute Kidney Injury,
pubmed-meshheading:20689322-Aged,
pubmed-meshheading:20689322-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20689322-Biological Markers,
pubmed-meshheading:20689322-Calcium,
pubmed-meshheading:20689322-Creatinine,
pubmed-meshheading:20689322-Dexamethasone,
pubmed-meshheading:20689322-Doxorubicin,
pubmed-meshheading:20689322-Female,
pubmed-meshheading:20689322-Humans,
pubmed-meshheading:20689322-Kidney,
pubmed-meshheading:20689322-Male,
pubmed-meshheading:20689322-Melphalan,
pubmed-meshheading:20689322-Middle Aged,
pubmed-meshheading:20689322-Multiple Myeloma,
pubmed-meshheading:20689322-Multivariate Analysis,
pubmed-meshheading:20689322-Nitrosourea Compounds,
pubmed-meshheading:20689322-Prednisolone,
pubmed-meshheading:20689322-Prognosis,
pubmed-meshheading:20689322-Recovery of Function,
pubmed-meshheading:20689322-Renal Dialysis,
pubmed-meshheading:20689322-Survival Analysis,
pubmed-meshheading:20689322-Treatment Outcome,
pubmed-meshheading:20689322-Vincristine,
pubmed-meshheading:20689322-beta 2-Microglobulin
|
pubmed:year |
2011
|
pubmed:articleTitle |
Factors associated with recovery of renal function in patients with multiple myeloma who were treated with hemodialysis.
|
pubmed:affiliation |
Department of Nephrology, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
|
pubmed:publicationType |
Journal Article
|